News
2 Bridge is attending BioEquity and Knowledge for Growth
We are pleased to announce that 2 Bridge will be present at the next edition of Bio€quity and Knowledge for Growth, organized in Ghent, from May 14th – May 17th, 2018. We are very much looking forward to meeting you this week.
2 Bridge receives French Research Tax Credit accreditation (CIR)
We are pleased to inform you that the French Ministry of Higher Education, Research and Innovation has granted our company the French Research Tax Credit accreditation.
Microbiome – White Paper
Changes in the gut microbiome are associated with numerous diseases. Research shows – convincingly – that microbiome modulation may lead to a cure. Why is it then, that the efforts to treat patients by targeting the gut microbiome fail?
2 Bridge on the 2018 Belgian State Visit to Canada
We proudly announce that Ann Meulemans, CEO & Managing Partner of 2 Bridge, is taking part in the Belgian State Visit to Canada.
January New Hires
2 Bridge keeps on growing.
We are pleased to have welcomed three new team members in January, 2018.
How can you minimize the impact that Drug Transporters have on your project?
In just 3 pages you will learn which aspects to consider when progressing your small molecule project through Development.
2 Bridge is attending the symposium “Organ on a Chip: from Dream to Implementation”
We are happy to announce that our 2 Bridge colleague Maarten Huisman, Preclinical Director, is invited as a speaker to give a presentation at the Symposium “Organ on a chip: From dream to implementation”. The symposium organized in Leiden on Nov 30, 2017, is a dissemination event of the Early Research Program and aims to show … Continue reading “2 Bridge is attending the symposium “Organ on a Chip: from Dream to Implementation””
2 Bridge has welcomed a new team member
2 Bridge has welcomed Ronald van Brempt, Medical Doctor, as new team member.
2 Bridge is attending Immunity for Health
Our colleague Lien Lybaert, Scientific Project Manager, is attending the second edition of Immunity for Health in Antwerp on October 20th, 2017.
2 Bridge is attending the Global Precision Medicine & Biomarkers Leaders Summit in Munich
Our 2 Bridge colleague, Maarten Huisman, Preclinical Director, is attending the 4th Global Precision Medicine & Biomarkers Leaders Summit taking place in Munich, Germany, on Sept 21-22, 2017.